Ara
Toplam kayıt 15, listelenen: 1-10
Thrombolysis in pulmonary embolism: full-dose, low-dose, or catheter-directed thrombolysis?
(W B Saunders Co-Elsevier Inc, 2016)
Letter to the Editor
Metoprolol vs ivabradine in patients with mitral stenosis
(Elsevier Ireland Ltd, 2016)
[No abstract available]
Risk stratification in intermediate-risk acute pulmonary embolism
(W B Saunders Co-Elsevier Inc, 2016)
Obesity and atrial fibrillation
(Elsevier Ireland Ltd, 2016)
Letter to Editor
Predictors of mortality in sepsis
(W B Saunders Co-Elsevier Inc, 2016)
Coronary artery disease in outpatients with nonvalvular atrial fibrillation: results from the multicenter RAMSES study
(Lippincott Williams & Wilkins, 2016)
Background Nonvalvular atrial fibrillation (NVAF) frequently coexists with coronary artery disease (CAD). However, the optimal antithrombotic strategy for patients with concomitant CAD and NVAF is controversial. The aim ...
Prediction of atrial fibrillation risk in the community
(Elsevier Ireland Ltd, 2016)
Letter to editor
ReAl-life Multicenter Survey Evaluating Stroke prevention strategies in non-valvular atrial fibrillation (RAMSES study)
(Turkish Soc Cardiology, 2016)
Objective: Data regarding stroke prevention strategies in non-valvular atrial fibrillation (NVAF) are limited to vitamin K antagonists (VKAs). This study aimed to evaluate real-life stroke prevention strategies for NVAF ...
Stroke prevention in real-life practice
(W B Saunders Co-Elsevier Inc, 2016)
Real-life use of digoxin in patients with non-valvular atrial fibrillation: data from the RAMSES study
(Wiley, 2016)
What is known and objectiveAlthough inappropriate use of digoxin has been described in various populations, a real-world evaluation of patterns of digoxin prescription has not been well studied in patients with atrial ...